PARENTI, SANDRA
 Distribuzione geografica
Continente #
NA - Nord America 5.947
EU - Europa 2.957
AS - Asia 2.713
SA - Sud America 372
AF - Africa 81
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
Totale 12.087
Nazione #
US - Stati Uniti d'America 5.836
SG - Singapore 813
IT - Italia 764
GB - Regno Unito 724
CN - Cina 659
VN - Vietnam 327
HK - Hong Kong 313
DE - Germania 303
BR - Brasile 272
SE - Svezia 252
FR - Francia 223
BD - Bangladesh 135
FI - Finlandia 133
RU - Federazione Russa 122
PL - Polonia 83
KR - Corea 77
UA - Ucraina 77
TR - Turchia 72
IN - India 67
ID - Indonesia 65
CA - Canada 61
IE - Irlanda 55
BG - Bulgaria 36
MX - Messico 33
AR - Argentina 32
JP - Giappone 30
ZA - Sudafrica 30
IQ - Iraq 29
NL - Olanda 28
BE - Belgio 23
AE - Emirati Arabi Uniti 19
CL - Cile 18
CO - Colombia 17
ES - Italia 17
CH - Svizzera 16
CZ - Repubblica Ceca 15
LT - Lituania 14
PK - Pakistan 14
SI - Slovenia 14
SA - Arabia Saudita 13
EC - Ecuador 11
MY - Malesia 11
RO - Romania 11
AT - Austria 10
UZ - Uzbekistan 10
MA - Marocco 9
KE - Kenya 8
EG - Egitto 7
MD - Moldavia 7
PE - Perù 7
AU - Australia 6
JO - Giordania 6
NP - Nepal 6
BO - Bolivia 5
DZ - Algeria 5
EU - Europa 5
GR - Grecia 5
PY - Paraguay 5
VE - Venezuela 5
AZ - Azerbaigian 4
ET - Etiopia 4
IL - Israele 4
IR - Iran 4
LB - Libano 4
PA - Panama 4
TN - Tunisia 4
XK - ???statistics.table.value.countryCode.XK??? 4
AL - Albania 3
BN - Brunei Darussalam 3
BY - Bielorussia 3
DK - Danimarca 3
GH - Ghana 3
OM - Oman 3
PH - Filippine 3
PR - Porto Rico 3
RS - Serbia 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
CG - Congo 2
CR - Costa Rica 2
EE - Estonia 2
GT - Guatemala 2
HN - Honduras 2
KG - Kirghizistan 2
KW - Kuwait 2
MN - Mongolia 2
NA - Namibia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AM - Armenia 1
BH - Bahrain 1
BJ - Benin 1
BW - Botswana 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
Totale 12.071
Città #
Ashburn 654
Singapore 515
Santa Clara 496
Southend 477
Fairfield 476
Chandler 320
Hong Kong 303
San Jose 290
Woodbridge 275
Houston 225
Ann Arbor 190
Seattle 190
Cambridge 165
Wilmington 150
Beijing 145
Hefei 142
Nyköping 141
Dearborn 137
New York 133
Modena 130
Chicago 123
Council Bluffs 123
London 119
Jacksonville 118
Los Angeles 117
Helsinki 96
Ho Chi Minh City 94
Hanoi 75
Seoul 74
Kraków 64
Milan 57
Dublin 54
The Dalles 53
Jakarta 48
Salt Lake City 45
San Diego 45
Munich 43
Bologna 38
Izmir 38
Princeton 38
Reggio Emilia 38
Moscow 35
Shanghai 35
Sofia 35
Buffalo 34
Fremont 34
Bremen 33
Dallas 32
Lauterbourg 32
Frankfurt am Main 30
Eugene 26
Redwood City 24
São Paulo 24
Tokyo 24
Denver 22
Tampa 21
Brussels 20
Orem 20
Boardman 19
San Giuliano Milanese 19
Atlanta 18
Da Nang 18
Falls Church 18
Nuremberg 18
Rome 18
Dong Ket 17
Phoenix 17
Warsaw 17
Elk Grove Village 16
Toronto 16
Des Moines 15
Johannesburg 15
Baghdad 14
Haiphong 14
Lancaster 14
Montreal 14
Turku 14
Düsseldorf 13
Mexico City 13
Miami 13
Sterling 13
Amsterdam 12
Brooklyn 12
Belo Horizonte 11
Charlotte 11
Columbus 11
Poplar 11
Guangzhou 10
Lawrence 10
Palermo 10
Paris 10
Parma 10
Rio de Janeiro 10
Boston 9
Naples 9
Portsmouth 9
Querétaro 9
San Francisco 9
Florence 8
Formigine 8
Totale 8.087
Nome #
MafB is a downstream target of the IL-10/STAT3 signaling pathway, involved in the regulation of macrophage de-activation 469
ERBB2 mutations in hormone receptor positive primary breast cancers samples and in their matched endocrine-resistant recurrences. 424
The vitamin D3/Hox-A10 pathway supports MafB function during the monocyte differentiation of human CD34+ hemopoietic progenitors 418
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 416
ZFP36 stabilizes RIP1 via degradation of XIAP and cIAP2 thereby promoting ripoptosome assembly 404
TFE3 transcription factor regulates the expression of MAFB during macrophage differentiation 403
Loss of zfp36 expression in colorectal cancer correlates to wnt/ ß-catenin activity and enhances epithelial-to-mesenchymal transition through upregulation of zeb1, sox9 and macc1 391
Down-regulation of μ-protocadherin expression is a common event in colorectal carcinogenesis 383
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 375
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications 366
Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database 363
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 352
A novel 2,3-benzodiazepine-4-one derivative AMPA antagonist inhibits G2/M transition and induces apoptosis in human leukemia Jurkat T cell line 350
Tfe3 expression is closely associated to macrophage terminal differentiation of human hematopoietic myeloid precursors. 333
ZFP36L1 Negatively Regulates Erythroid Differentiation of CD34+ Hematopoietic Stem Cells by Interfering with Stat5b Pathway. 322
Gene expression profiles of human granulosa cells treated with bioequivalent doses of corifollitropin alfa (CFA) or recombinant human follicle-stimulating hormone (recFSH) 318
The Orosomucoid1 protein is involved in the vitamin D – mediated macrophage de-activation process 310
Loss of expression of μ-protocadherin and protocadherin-24 in sporadic and hereditary nonpolyposis colorectal cancers 310
Physiological expression of miR-130a during differentiation of CD34+ human hematopoietic stem cells results in the inhibition of monocyte differentiation 296
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 294
Alpha – 1 – acid glycoprotein-A is a new VDR transcriptional target involved in monocyte differentiation and activation processes. 294
Promoter Methylation Leads to Decreased ZFP36 Expression and Deregulated NLRP3 Inflammasome Activation in Psoriatic Fibroblasts 283
STRATEGIES TO PREDICT TREATMENT RESPONSE AND SELECT THERAPIES IN METASTATIC BREAST CANCER PATIENTS USING A NEXT GENERATION SEQUENCING (NGS) MULTI-GENE PANEL 278
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 278
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis 271
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis 269
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 263
Genomic analysis of hematopoietic stem cell at the single-cell level: Optimization of cell fixation and whole genome amplification (WGA) protocol 254
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis 245
Characterization of new ATM deletion associated with hereditary breast cancer 243
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 241
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms 239
Mesalazine inhibits the beta-catenin signalling pathway acting through the upregulation of mu-protocadherin gene in colo-rectal cancer cells 236
Magnesium is a key regulator of the balance between osteoclast and osteoblast differentiation in the presence of vitamin D 3 227
Novel Molecular Insights into Leukemic Evolution of Myeloproliferative Neoplasms: A Single Cell Perspective 214
Chemoprevention of colorectal cancer 211
Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis 202
Magnesium favors the capacity of vitamin d3 to induce the monocyte differentiation of u937 cells 197
Targeting exhausted cytotoxic T cells through CTLA‐4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts 171
Clonal dynamics and copy number variants by single‐cell analysis in leukemic evolution of myeloproliferative neoplasms 156
CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis 101
Combined MEK and JAK inhibition reduces osteopontin plasma level and bone marrow fibrosis in a myelofibrosis mouse model 25
Totale 12.195
Categoria #
all - tutte 45.397
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.397


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022869 46 59 75 35 33 58 61 68 91 82 149 112
2022/2023995 114 121 79 95 103 110 27 91 156 17 35 47
2023/2024654 35 27 58 72 125 60 55 91 9 12 38 72
2024/20252.213 71 22 32 122 461 331 182 143 204 115 255 275
2025/20264.159 285 100 263 478 734 266 532 178 425 396 298 204
2026/202776 76 0 0 0 0 0 0 0 0 0 0 0
Totale 12.195